Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Nascer e Crescer
versión impresa ISSN 0872-0754versión On-line ISSN 2183-9417
Resumen
RANGEL, Maria Adriana et al. Endocrine disorders in children with neurofibromatosis type 1: What to look for?. Nascer e Crescer [online]. 2022, vol.31, n.4, pp.354-363. Epub 31-Dic-2022. ISSN 0872-0754. https://doi.org/10.25753/birthgrowthmj.v31.i4.25986.
Neurofibromatosis type 1 (NF1) is one of the most common genetic disorders, with a reported incidence of 1:3000. The condition is multisystemic, and diagnostic criteria have been recently revised as an international consensus recommendation. The clinical features evolve slowly and progressively and may often be absent in early childhood. Disorders of growth and endocrine conditions, although described for several decades in these children, are not included in the diagnostic criteria. However, they are relatively frequent and may be the presenting feature of optic pathway glioma. Due to its wide spectrum of health implications, children with NF1 are often followed at Pediatric consultation.
The aim of this article is to review the most frequent endocrine disorders in NF1 patients, what to look for, and when to refer patients to pediatric Endocrinology consultation.
Palabras clave : endocrine system diseases; growth and development; neurofibromatosis 1; Pediatrics.